TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01763099

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells
Description: Mesenchymal stem cells will be intravenously infused via a central venous catheter(at a dose of 1×10\^6 cells/kg, over 15 min) in day 1 and day 15 of the cycle. If the NEU and PLT levels do not attain the completely response(CR)standards after this cycle, mesenchymal stem cells combined with cord blood will be given. If the NEU and PLT levels attain the completely response(CR)or partly response(PR) standards after this cycle, another cycle with the same strategy will be given.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells and cord blood
Description: Mesenchymal stem cells will be given (at a dose of 1×10\^6 cells/kg,intravenously infused via a central venous catheter)on day 1.day 15, day 29 and day 43 of the cycle. Cord blood will be given intravenously infused via a central venous catheter on day 2 of the cycle.
Study: NCT00862927

Intervention type: OTHER
Intervention: Breath Sample
Description: Breathe into machine measuring carbon monoxide.

Intervention type: OTHER
Intervention: Saliva Sample
Description: Chew cotton ball for 30 seconds for cotinine measurement.

Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: 6 surveys, taking approximately 30 minutes total.

Intervention type: BEHAVIORAL
Intervention: View Virtual Reality Scenes
Description: Use virtual reality helmet and hand-held controller to answer questions about 4 viewing scenes while wearing physiological measurement skin sensors, approximately 6 minutes.
Study: NCT03324282

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Avelumab
Description: Combination of Gemcitabin-Cisplatin and avelumab given for 6 cycles (each cycle is 21 days)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GC
Description: Combination of Gemcitabin-Cisplatin given for 6 cycles (each cycle is 21 days)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GC
Description: Combination of Gemcitabin-Cisplatin given for 6 cycles (each cycle is 21 days)
Study: NCT03268603

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Autologous Adipose-derived Mesenchymal Stromal Cells
Description: The investigational product consists of autologous adipose-derived Mesenchymal Stromal Cells (MSCs), suspended in 5-10 mL Lactated Ringer's. The MSC are provided in a sterile syringe labelled with appropriate patient and product identifiers ready for intrathecal injection.
Study: NCT00040885

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: infliximab
Study: NCT02893618

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diazoxide choline controlled-release tablet
Description: QD tablet formulation of choline salt of diazoxide

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diazoxide choline controlled-release tablet
Description: QD tablet formulation of choline salt of diazoxide
Study: NCT04153799

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CXCR5 modified EGFR Chimeric Antigen Receptor Autologous T cells
Description: The first dose group: 0.5 × 10\^6/kg CAR positive T cells; The second dose group: 1.58 × 10\^6 / kg CAR positive T cells; The third dose group: 5 × 10\^6/kg CAR positive T cells. The above dose allows a 20 % error; For subjects with body weight greater than 60 kg, the number of cells can only be calculated according to 60 kg of body weight.
Study: NCT00040885

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: docetaxel

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: docetaxel
Study: NCT01289145

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational intervention
Description: The motivational intervention promotes positive outcome expectancies on physical activity.
Study: NCT03506802

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 18F-FHBG
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Aldesleukin
Description: Given SC

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Cellular Therapy
Description: LV-NYESO TCR /sr39TK PBSC and RV-NYESO TCR PBMC given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Filgrastim
Description: Given SC

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Given PO

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Plerixafor
Description: Given SC

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study: NCT04117386

Intervention type: DIAGNOSTIC_TEST
Intervention: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
Description: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)

Intervention type: DIAGNOSTIC_TEST
Intervention: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
Description: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)

Intervention type: DIAGNOSTIC_TEST
Intervention: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong)
Description: HPV genotyping assay using HPV GenoArray Diagnostic Kits (Hybribio Ltd., Sheung Wan, Hong Kong) for swab sample collected from pterygium and normal conjunctiva and also for urine collected in Colli-PeeTM device (Novosanis, Belgium)

Intervention type: DIAGNOSTIC_TEST
Intervention: Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Description: Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Study: NCT01289145

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Volitional intervention
Description: The volitional intervention promotes the formulation of action plans for physical activity.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Control
Description: Participants receive a quiz on physical activity and sports.
Study: NCT04012788

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Synbiotic mixture
Description: A synbiotic mixture consisting of four probiotic strains and inulin (a prebiotic)
Study: NCT03157765

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: endometrial biopsy
Description: endometrial biopsy
Study: NCT04674488

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TILs
Description: a single center, single-arm, open label, interventional study
Study: NCT01167660

Intervention type: DEVICE
Intervention: The Thrombo-Monitor (ThM)
Description: Non-invasive measurement of coagulation status and comparison to standard blood coagulation tests. In healthy neonates - immediately after birth, before the administration of vitamin K. Coagulation tests will be done on an umbilical cord blood sample. In sick neonates, coagulation studies will be done according to the medical condition.

Intervention type: DEVICE
Intervention: The Thrombo-Monitor (ThM)
Description: Non-invasive measurement of coagulation status and comparison to standard blood coagulation tests. In healthy neonates - immediately after birth, before the administration of vitamin K. Coagulation tests will be done on an umbilical cord blood sample. In sick neonates, coagulation studies will be done according to the medical condition.
Study: NCT02750839

Intervention type: PROCEDURE
Intervention: proximal humerus fracture fixation
Description: Mini-invasive proximal humerus fixation with plate, patient in beach chair position, general anesthesia, a small incision lateral to shoulder is made to insert the plate under scope control
Study: NCT04117386

Intervention type: DIAGNOSTIC_TEST
Intervention: Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Description: Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip

Intervention type: DIAGNOSTIC_TEST
Intervention: Bio-Plex® 200 system (Bio- Rad, Hercules, CA)
Description: Bioplex was use for measure cytokine IL-6, IL-18 and VEGF from tears collected from Schirmer strip
Study: NCT00212459

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling
Description: Patients are contacted every two weeks after initial counseling to discuss the completion of bleeding records.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: No more contacts are made with control patients after the initial counseling session.
Study: NCT03677986

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video DOT+
Description: Participants will receive financial incentives for recording and submitting videos of themselves taking their daily buprenorphine dose.
Study: NCT01130220

Intervention type: OTHER
Intervention: Focus Group
Description: A single focus group will be held until a saturation of themes has been identified.

Intervention type: OTHER
Intervention: Focus Group
Description: A single focus group will be held until a saturation of themes has been identified.
Study: NCT04229940

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peritoneal bridging
Description: The defect is covered by peritoneal bridging

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: No peritoneal bridging
Description: The defect is left without bridging
Study: NCT04412174

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GC022F
Description: GC022F is a bispecific CAR-T cell immunotherapy that targeted CD19 and CD22. The dosage ranges from 3×10\^5 to 1×10\^6 CAR+T/Kg.
Study: NCT01874470

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: renal denervation

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard medication

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: standard medication
Study: NCT05081778

Intervention type: BEHAVIORAL
Intervention: Obese patient following a medical course
Description: Questionnaires for the assessment of dissociative disorders in obese patients : DES scale of Carlson and Putman, SDQ-20 of Nijenhuis, comorbidities, Dutch Eating Behaviour Questionnaire (DEBQ), questionnaire of Rosenberg

Intervention type: BEHAVIORAL
Intervention: Obese patient following a medical course
Description: Questionnaires for the assessment of dissociative disorders in obese patients : DES scale of Carlson and Putman, SDQ-20 of Nijenhuis, comorbidities, Dutch Eating Behaviour Questionnaire (DEBQ), questionnaire of Rosenberg
Study: NCT03771261

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Weight Loss
Description: Participants will be prescribed hypo-caloric diet by a registered dietitian and attend weekly social support/nutrition education meetings.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Weight Loss
Description: Participants will be prescribed hypo-caloric diet by a registered dietitian and attend weekly social support/nutrition education meetings.

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Egg Protein
Description: Participants will be provided pre-packaged hard-boiled eggs (3/day, medium) and egg white protein powder.
Study: NCT00383500

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Flexitouch
Description: A standard of care intermittent pneumatic compression device (aka, lymphedema pump)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Class 1 compression garment
Description: Manual lymphatic drainage therapy to provide lymphatic massage, using a Class 1 compression garment supporting the arm during heavy exercise or where the risk of trauma maybe increased (ie, flight, elevation, etc).
Study: NCT02923076

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CCR5 delta32/delta32 cord blood transplantation
Study: NCT00208533

Intervention type: DRUG
Group type: OTHER
Intervention: Aripiprazole
Description: Aripiprazole 5 mg to 30mg, individually titrated
Study: NCT06583694

Intervention type: BEHAVIORAL
Intervention: Health promotion campaigns to correct the health problems

Intervention type: BEHAVIORAL
Intervention: Health promotion campaigns to correct the health problems

Intervention type: BEHAVIORAL
Intervention: Health promotion campaigns to correct the health problems

Intervention type: BEHAVIORAL
Intervention: Health promotion campaigns to correct the health problems

Intervention type: BEHAVIORAL
Intervention: Health promotion campaigns to correct the health problems
Study: NCT00927238

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: XL TDR
Description: This will be a lateral approach discectomy and reconstruction with the insertion of the XL TDR device.

Intervention type: OTHER
Group type: OTHER
Intervention: Lumbar fusion surgery
Description: Lumbar fusion surgery

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Lumbar fusion surgery
Description: Lumbar fusion surgery
Study: NCT04638114

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mini-open DAA
Description: Direct anterior approach hip

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Mini-open DAA
Description: Direct anterior approach hip

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hip arthroscopy
Description: arthroscopic treatment of hip pathology

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Hip arthroscopy
Description: arthroscopic treatment of hip pathology
Study: NCT06166368

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diurnal variation
Description: Venous blood samples were obtained under standardized circumstances from 24 healthy young men every third hour through 24 hours, nine time points in total.
Study: NCT03305315

Intervention type: OTHER
Intervention: Measurements of jaw movement
Description: Jaw mobility will be measured during simple movements of the mouth (opening the mouth, side-to-side and backwards-and-forwards movement of the jaw). These movements will be measured using a specific apparatus, part of which will be placed on the head like a helmet with the other part placed in the mouth and stuck to the teeth using a dental adhesive. The part in the mouth is specifically designed for this purpose. Measurements using this apparatus will take around 30 minutes.

Intervention type: OTHER
Intervention: Measurement of natural electrical activity of facial muscles
Description: Natural electrical activity of the facial muscles will be measured using electrodes placed on the skin.

Intervention type: OTHER
Intervention: Measurement of natural electrical activity of facial muscles
Description: Natural electrical activity of the facial muscles will be measured using electrodes placed on the skin.
Study: NCT00151476

Intervention type: DRUG
Intervention: Celecoxib
Description: 800 mg total daily dosing

Intervention type: OTHER
Intervention: Routine Medical Care
Study: NCT04443855

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Nutrition, Water quality, Sanitation, Hand washing
Description: Each of the interventions described above for Water Quality, Sanitation \& Hand washing (Combined WASH) Plus the intervention described above for nutrition.
Study: NCT03831581

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Erector Spinae Plane Block
Description: In patients with chest pain, ultrasound-guided Erector Spinae Plane Block block was performed at T5 transverse process in the cephalo-caudal direction with Tuohy 18 gauge needle in plane until the needle tip was located in the interfascial plane between the transverse process and the erector spinae muscles, 20 ml of bupivacaine 0.5% was administered and a catheter was inserted if indicated.
Study: NCT03931928

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Z)-Endoxifen supplementation according to genotype
Description: Group 2: CYP2D6 genotype predicted intermediate metabolizer receive 1.5 mg, poor metabolizer receive 3 mg (Z)-Endoxifen and extensive or ultrarapid metabolizer receive 0 mg endoxifen (Placebo)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: (Z)-Endoxifen supplementation according to plasma levels
Description: Group 3: Patients will receive (Z)-endoxifen according to (Z)-endoxifen steady state plasma concentrations (phenotype) at screening (i.e. ≤ 15 nM receive 3 mg, \> 15 and ≤ 25 nM receive 1.5 mg (Z)-Endoxifen and \> 25 nM receive 0 mg (Placebo)
Study: NCT00856947

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Cholecalciferol D3
Description: 2 tablets of 1200 IU daily from week 24 of gestation to 1 week after delivery

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo tablet
Description: 2 tablets containing no active substance
Study: NCT01552356

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pazopanib Hydrochloride
Description: Given PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study: NCT02227199

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab Vedotin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab Vedotin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brentuximab Vedotin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV
Study: NCT04710459

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: cryotherapy
Description: Group 1 included 30 patients, they were subjected to chemoradiotherapy plus endobronchial cryotherapy. Group 2 included include 30 patients, they were subjected to chemoradiotherapy.
Study: NCT01567046

Intervention type: OTHER
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study: NCT04640792

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Screening or Surveillance Conventionall colonoscopy
Description: Patients in Group A (CC) will undergo Screening or Surveillance Conventual Colonoscopy, Patients in Group B (MEAC) will undergo Screening or Surveillance Colonoscopy with ME-ADPS Device
Study: NCT04390711

Intervention type: OTHER
Intervention: High density lipoprotein isolation, detection and in-vitro study.
Description: All blood samples were taken on the day of cardiac catheterization after overnight fasting.High density lipoprotein from each participants was isolated and further collected for carbamylation level detection and in-vitro study.

Intervention type: OTHER
Intervention: High density lipoprotein isolation, detection and in-vitro study.
Description: All blood samples were taken on the day of cardiac catheterization after overnight fasting.High density lipoprotein from each participants was isolated and further collected for carbamylation level detection and in-vitro study.

Intervention type: OTHER
Intervention: High density lipoprotein isolation, detection and in-vitro study.
Description: All blood samples were taken on the day of cardiac catheterization after overnight fasting.High density lipoprotein from each participants was isolated and further collected for carbamylation level detection and in-vitro study.
Study: NCT03752502

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS)
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripheral electrical stimulation (PES)
Description: Peripheral electrical stimulation (PES) activates a complex neural network involving a series of neurotransmitters and receptors capable of promoting segmental and extrasegmental analgesia.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Peripheral electrical stimulation (PES)
Description: Peripheral electrical stimulation (PES) activates a complex neural network involving a series of neurotransmitters and receptors capable of promoting segmental and extrasegmental analgesia.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sham tDCS
Description: Transcranial direct current stimulation (tDCS) is a noninvasive brain stimulation (NIBS) technique that has been investigated for the management of various chronic pain conditions. However, as a monotherapy for pain relief, this therapy still has controversial results.
Study: NCT00040885

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: placebo
Study: NCT02227199

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: Given IV